FATE
Fate Therapeutics Inc
Price:  
3.61 
USD
Volume:  
1,964,431.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FATE Stock Forecast & Price Target

FATE Stock Price Forecast

The average stock forecast for Fate Therapeutics Inc (FATE) in the next 12 months is 6.92 USD. This price target corresponds to an upside of 91.73%. The range of stock forecasts for FATE is 4.04 - 12.60 USD. Based on the ratings of 24 analysts, the consensus recommendation for FATE is HOLD.
Target Low Average Median High
Price (USD) 4.04 6.92 6.12 12.60
Upside 11.91% 91.73% 69.53% 249.03%

Recommendation Trends

The latest consensus rating for FATE is "HOLD". This is the average recommendation of 24 analysts: 0 strong sell, 1 sell, 12 hold, 6 buy, 5 strong buy. In the previous period, 26 analysts also majorly recommmended "HOLD" for FATE.

FATE Financial Stock Forecast

Revenue This Year
4.63M
-92.71%
from 63.53M
Revenue Next Year
3.39M
-26.88%
from 4.63M
EPS This Year
-1.92
35.59%
from -1.41
EPS Next Year
-1.87
-2.45%
from -1.92